Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathophysiological mechanisms underlying tardive dyskinesia.

J Gerlach

    Psychopharmacology. Supplementum
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    THE MIDLATITUDE CONTINENTAL CONVECTIVE CLOUDS EXPERIMENT (MC3E).

    Bulletin of the American Meteorological Society·2020
    Same author

    Improved method for MR microscopy of brain tissue cultured with the interface method combined with Lenz lenses.

    Magnetic resonance imaging·2018
    Same author

    Hypersensitivity pneumonitis and antigen identification--An alternate approach.

    Respiratory medicine·2016
    Same author

    Principles of practice from the European expert panel on the contemporary treatment of schizophrenia.

    International journal of psychiatry in clinical practice·2014
    Same author

    Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity.

    Journal of psychopharmacology (Oxford, England)·2012
    Same author

    Extracellular serine proteases from Stenotrophomonas maltophilia: Screening, isolation and heterologous expression in E. coli.

    Journal of biotechnology·2011
    Same journal

    Pharmacological properties of presynaptic dopamine receptor agonists.

    Psychopharmacology. Supplementum·1985
    Same journal

    Behavioral effects of long-term neuroleptic treatment in Cebus monkeys.

    Psychopharmacology. Supplementum·1985
    Same journal

    Intermittent treatment with droperidol, a short-acting neuroleptic, increases behavioral dopamine receptor sensitivity.

    Psychopharmacology. Supplementum·1985
    Same journal

    Pathophysiology of tardive dyskinesia.

    Psychopharmacology. Supplementum·1985
    Same journal

    Dyskinesia. Research and treatment.

    Psychopharmacology. Supplementum·1985
    Same journal

    Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats.

    Psychopharmacology. Supplementum·1985
    See all related articles

    Neuroleptic treatment can cause movement disorders like initial dyskinesia and tardive dyskinesia. These conditions may stem from complex neurotransmitter imbalances, not just dopamine hypersensitivity.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Pharmacology

    Background:

    • Neuroleptic medications are associated with various movement abnormalities in psychiatric patients.
    • These movement disorders are broadly categorized into initial syndromes, tardive syndromes, and age/schizophrenia-related movements.
    • Initial syndromes are dose-dependent, while tardive syndromes can emerge after drug withdrawal.

    Purpose of the Study:

    • To classify and differentiate neuroleptic-induced movement abnormalities.
    • To explore the underlying pathophysiology of tardive dyskinesia (TD).
    • To propose a more comprehensive model for understanding these complex movement disorders.

    Main Methods:

    • Classification of movement abnormalities based on clinical presentation and timing relative to neuroleptic treatment.

    Related Experiment Videos

  • Review of existing literature and animal experimental data on dopamine receptor function.
  • Analysis of potential mechanisms involving multiple neurotransmitter systems.

    • Main Results:

    • Movement abnormalities are categorized into initial (dose-related) and tardive (withdrawal-related) syndromes.
    • Initial dyskinesia and tardive dyskinesia can co-occur and share underlying mechanisms.
    • Animal models suggest differential effects of dopamine receptor blockade in various brain regions, explaining concurrent parkinsonism and hyperkinesia.

    Conclusions:

    • The traditional dopamine hypersensitivity model is insufficient to explain tardive dyskinesia.
    • Tardive dyskinesia is likely a heterogeneous syndrome influenced by a complex interplay of neurotransmitters.
    • Understanding the balance between dopamine receptor blockade and hypersensitivity of dopamine and GABA receptors is crucial for elucidating TD pathophysiology.